Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries/territories in 2022.

Saved in:
Bibliographic Details
Title: Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries/territories in 2022.
Authors: Li P; Department of Epidemiology, Shanghai Key Laboratory of Medical Bioprotection, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai 200433, China., Ding Z; Department of Epidemiology, Shanghai Key Laboratory of Medical Bioprotection, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai 200433, China., Feng Y; Department of Epidemiology, Shanghai Key Laboratory of Medical Bioprotection, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai 200433, China., Ren X; Department of Epidemiology, Shanghai Key Laboratory of Medical Bioprotection, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai 200433, China., Wei Y; Center for Public Health and Epidemic Preparedness and Response, Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Xia C; National Central Cancer Registry & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China., Yang Y; School of Basic Medicine, Second Military Medical University, Shanghai 200433, China., Yang Q; School of Basic Medicine, Second Military Medical University, Shanghai 200433, China., Wang Z; School of Basic Medicine, Second Military Medical University, Shanghai 200433, China., Zhang X; School of Nursing, Yale University, New Haven, CT 06520, USA., van der Geest LG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht 3511, The Netherlands., Yu H; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813 USA., Giovannucci E; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA., Smith DP; The Daffodil Centre, the University of Sydney, a joint venture with Cancer Council NSW, Sydney 2011, Australia., David M; The Daffodil Centre, the University of Sydney, a joint venture with Cancer Council NSW, Sydney 2011, Australia., Jemal A; Surveillance and Health Equity Science, American Cancer Society, Atlanta, GA 30303, USA., Yu XQ; The Daffodil Centre, the University of Sydney, a joint venture with Cancer Council NSW, Sydney 2011, Australia. Electronic address: xueqiny@nswcc.org.au., Zeng H; National Central Cancer Registry & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: hongmeizeng@cicams.ac.cn., Cao G; Department of Epidemiology, Shanghai Key Laboratory of Medical Bioprotection, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai 200433, China. Electronic address: gcao@smmu.edu.cn.
Source: Science bulletin [Sci Bull (Beijing)] 2026 Feb 28; Vol. 71 (4), pp. 838-849. Date of Electronic Publication: 2025 Dec 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101655530 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2095-9281 (Electronic) Linking ISSN: 20959273 NLM ISO Abbreviation: Sci Bull (Beijing) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2095-9281
DOI:10.1016/j.scib.2025.12.022